Combination of apoptin with photodynamic therapy induces nasopharyngeal carcinoma cell death in vitro and in vivo

Fang,Xiaoyong; Wu,Ping; Li,Jinyun; Qi,Lin; Tang,Yaoyun; Jiang,Weihong; Zhao,Suping

doi:10.3892/or.2012.2044

Combination of apoptin with photodynamic therapy induces nasopharyngeal carcinoma cell death in vitro and in vivo

Authors:
- Xiaoyong Fang
- Ping Wu
- Jinyun Li
- Lin Qi
- Yaoyun Tang
- Weihong Jiang
- Suping Zhao
View Affiliations

Affiliations: Department of Otolaryngology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, P.R. China
Published online on: September 19, 2012 https://doi.org/10.3892/or.2012.2044
Pages: 2077-2082

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Photodynamic therapy has been developed as a viable treatment for cancer, while apoptin is an apoptosis-inducing protein. This study was undertaken to evaluate the feasibility and efficacy of apoptin with photodynamic therapy (PDT) in the treatment of nasopharyngeal carcinoma (NPC). RT-PCR and western blotting were used to detect the expression of apoptin in CNE-2 NPC cells. MTT and flow cytometry analysis were used to detect cell proliferation and cell apoptosis, respectively. Transmission electron microscopy was used to observe cell structures. Hematoxylin and eosin staining was used to observe the xenograft morphology. The expression of apoptin was analyzed by RT-PCR and western blotting in CNE-2 cells stably transfected with PVP3 plasmid. Apoptin restrained cell proliferation and enhanced cell apoptosis compared to controls. Furthermore, we demonstrated that apoptin augmented the effect of PDT with stronger cell proliferation restraint and cell apoptosis and induced severe ultrastructural morphology changes compared to controls. Additionally, we found that the combination of apoptin and PDT produced the strongest inhibition of xenograft growth and tumor necrosis in in vivo experiments. Collectively, we show that apoptin in combination with PDT has a better therapeutic effect in NPC than PDT therapy or apoptin gene therapy alone.

View Figures

View References

1	Yu MC and Yuan JM: Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 12:421–429. 2002. View Article : Google Scholar : PubMed/NCBI
2	Chow E, Payne D, O’Sullivan B, Pintilie M, Liu FF, Waldron J, Warde P and Cummings B: Radiotherapy alone in patients with advanced nasopharyngeal cancer: comparison with an intergroup study. Is combined modality treatment really necessary? Radiother Oncol. 63:269–274. 2002. View Article : Google Scholar
3	Fritsch C, Goerz G and Ruzicka T: Photodynamic therapy in dermatology. Arch Dermatol. 134:207–214. 1998. View Article : Google Scholar
4	Roscetti G, Franzese O, Comandini A and Bonmassar E: Cytotoxic activity of Hypericum perforatum L on K562 erythroleukemic cells: differential effects between methanolic extract and hypericin. Phytother Res. 18:66–72. 2004. View Article : Google Scholar : PubMed/NCBI
5	Kiesslich T, Krammer B and Plaetzer K: Cellular mechanisms and prospective applications of hypericin in photodynamic therapy. Curr Med Chem. 13:2189–2204. 2006. View Article : Google Scholar : PubMed/NCBI
6	Kim CH, Chung CW, Choi KH, Yoo JJ, Kim do H, Jeong YI and Kang DH: Effect of 5-aminolevulinic acid-based photodynamic therapy via reactive oxygen species in human cholangiocarcinoma cells. Int J Nanomed. 6:1357–1363. 2011.PubMed/NCBI
7	Kamoshima Y, Terasaka S, Kuroda S and Iwasaki Y: Morphological and histological changes of glioma cells immediately after 5-aminolevulinic acid mediated photodynamic therapy. Neurol Res. 33:739–746. 2011. View Article : Google Scholar : PubMed/NCBI
8	Park JH, Moon YH, Kim DJ, Kim SA, Lee JB, Ahn SG and Yoon JH: Photodynamic therapy with hexenyl ester of 5-aminolevulinic acid induces necrotic cell death in salivary gland adenocarcinoma cells. Oncol Rep. 24:177–181. 2010.PubMed/NCBI
9	Los M, Wesselborg S and Schulze-Osthoff K: The role of caspases in development, immunity, and apoptotic signal transduction: lessons from knockout mice. Immunity. 10:629–639. 1999. View Article : Google Scholar : PubMed/NCBI
10	Schwerk C and Schulze-Osthoff K: Regulation of apoptosis by alternative pre-Mrna splicing. Mol Cell. 19:1–13. 2005. View Article : Google Scholar : PubMed/NCBI
11	Fischer U, Jänicke RU and Schulze-Osthoff K: Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ. 10:76–100. 2003. View Article : Google Scholar : PubMed/NCBI
12	Noteborn MH, Todd D, Verschueren CA, de Gauw HW, Curran WL, Veldkamp S, Douglas AJ, McNulty MS, van der EBAJ and Koch G: A single chicken anemia virus protein induces apoptosis. J Virol. 68:346–351. 1994.PubMed/NCBI
13	Maddika S, Mendoza FJ, Hauff K, Zamzow CR, Paranjothy T and Los M: Cancer selective therapy of the future: apoptin and its mechanism of action. Cancer Biol Ther. 5:10–19. 2006. View Article : Google Scholar : PubMed/NCBI
14	Noteborn MH: Chicken anemia virus induced apoptosis: underlying molecular mechanisms. Vet Microbiol. 98:89–94. 2004. View Article : Google Scholar : PubMed/NCBI
15	Heilman DW, Teodoro JG and Green MR: Apoptin nucleocytoplasmic shuttling is required for cell type-specific localization, apoptosis, and recruitment of the anaphase-promoting complex/cyclosome to PML bodies. J Virol. 80:7535–7545. 2006. View Article : Google Scholar
16	Poon IK, Oro C, Dias MM, Zhang J and Jans DA: Apoptin nuclear accumulation is modulated by a CRM1-recognized nuclear export signal that is active in normal but not in tumor cells. Cancer Res. 65:7059–7064. 2005. View Article : Google Scholar : PubMed/NCBI
17	Backendorf C, Visser AE, de Boer AG, Zimmerman R, Visser M, Voskamp P, Zhang YH and Noteborn M: Apoptin: therapeutic potential of an early sensor of carcinogenic transformation. Annu Rev Pharmacol Toxicol. 48:143–169. 2008. View Article : Google Scholar : PubMed/NCBI
18	Tavassoli M, Guelen L, Luxon BA and Gäken J: Apoptin: specific killer of tumor cells? Apoptosis. 10:717–724. 2005. View Article : Google Scholar : PubMed/NCBI
19	Zhuang SM, Shvarts A, van Ormondt H, Jochemsen AG, van der Eb AJ and Noteborn MH: Apoptin, a protein derived from chicken anemia virus, induces p53-independent apoptosis in human osteosarcoma cells. Cancer Res. 55:486–489. 1995.PubMed/NCBI
20	Burek M, Maddika S, Burek CJ, Daniel PT, Schulze-Osthoff K and Los M: Apoptin-induced cell death is modulated by Bcl-2 family members and is Apaf-1 dependent. Oncogene. 25:2213–2222. 2005. View Article : Google Scholar : PubMed/NCBI
21	Xie Y, Wei ZB, Zhang Z, Wen W and Huang GW: Effect of 5-ALA-PDT on VEGF and PCNA expression in human NPC-bearing nude mice. Oncol Rep. 22:1365–1371. 2009.PubMed/NCBI
22	Krieger MD, Couldwell WT and Weiss MH: Assessment of long term remission of acromegaly following surgery. J Neurosurg. 98:719–724. 2003. View Article : Google Scholar : PubMed/NCBI
23	Barnes LD, Giuliano EA, Ota J, Cohn LA and Moore CP: The effect of photodynamic therapy on squamous cell carcinoma in a murine model: evaluation of time between intralesional injection to laser irradimion. Vet J. 180:60–65. 2009. View Article : Google Scholar : PubMed/NCBI
24	Yung A, Stables GI, Fernandez C, Williams J, Boiar RA and Goulden V: Microbiological effect of photodynarnic therapy(PDT) in healthy volunteers: a comparative study using methyl aminolaevulinate and hexyl aminolaevulinate cream. Clin Exp Dermatol. 32:716–721. 2007. View Article : Google Scholar : PubMed/NCBI
25	Su ZA, Yao K, Shen J, Jiang JK, Fang XY, Lin JJ and DU XH: Evaluation of photodynamic therapy in idiopathic choroidal neovascularization. Zhonghua Yan Ke Za Zhi. 43:509–513. 2007.PubMed/NCBI
26	Luna MC, Chen X, Wong S, Tsui J, Rucker N, Lee AS and Gomer CJ: Enhanced photodynamic therapy efficacy with inducible suicide gene therapy controlled by the grp promoter. Cancer Res. 62:1458–1461. 2002.PubMed/NCBI
27	Laden BP, Tang Y and Porter TD: Cloning, heterologous expression, andenzymological characterization of human squalene monooxygenase. Arch Biochem Biophys. 374:381–388. 2000. View Article : Google Scholar : PubMed/NCBI
28	Teodoro JG, Heilman DW, Parker AE and Green MR: The viral protein Apoptin associates with the anaphase-promoting complex to induce G2/M arrest and apoptosis in the absence of p53. Genes Dev. 18:1952–1957. 2004. View Article : Google Scholar : PubMed/NCBI
29	Danen-van Oorschot AA, Voskamp P, Seelen MC, van Miltenburg MH, Bolk MW, Tait SW, Boesen-de Cock JG, Rohn JL, Borst J and Noteborn MH: Human death effector domain-associated factor interacts with the viral apoptosis agonist Apoptin and exerts tumor-preferential cell killing. Cell Death Differ. 11:564–573. 2004.
30	Janssen K, Hofmann TG, Jans DA, Hay RT, Schulze-Osthoff K and Fischer U: Apoptin is modified by SUMO conjugation and targeted to promyelocytic leukemia protein nuclear bodies. Oncogene. 26:1557–1566. 2007. View Article : Google Scholar : PubMed/NCBI
31	Krieghoff-Henning E and Hofmann TG: Role of nuclear bodies in apoptosis signaling. Biochim Biophys Acta. 1783:2185–2194. 2008. View Article : Google Scholar : PubMed/NCBI